• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Introduction to 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid (CAS No. 1305325-09-0)

7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid, identified by its Chemical Abstracts Service (CAS) number 1305325-09-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic compound belongs to the dioxino[2,3-bpyridine] scaffold, a structural motif that has been extensively explored for its potential biological activities. The presence of a chloro substituent and a carboxylic acid functional group further enhances its chemical reactivity, making it a valuable intermediate in the synthesis of various pharmacologically relevant molecules.

The dioxino[2,3-bpyridine] core of this compound is particularly intriguing due to its ability to modulate biological pathways through multiple mechanisms. Recent studies have highlighted the importance of such scaffolds in the development of novel therapeutic agents, particularly in the areas of anticancer and anti-inflammatory research. The 7-chloro group introduces electrophilicity, which can be exploited for further functionalization, while the 8-carboxylic acid moiety provides a site for amide or ester bond formation, enabling the construction of more complex derivatives.

In contemporary pharmaceutical research, the synthesis and characterization of 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid have been instrumental in exploring new drug candidates. The compound’s structural features suggest potential interactions with enzymes and receptors involved in disease progression. For instance, modifications to the bpyridine ring can influence binding affinity and selectivity, which are critical factors in drug design. Preliminary computational studies have indicated that this scaffold may exhibit favorable pharmacokinetic properties, including improved solubility and metabolic stability.

One of the most compelling aspects of this compound is its versatility as a building block. Researchers have leveraged its unique structure to develop libraries of derivatives for high-throughput screening (HTS) campaigns. These efforts have led to the identification of several lead compounds with promising biological activity. Notably, derivatives of 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid have shown efficacy in preclinical models of inflammation and tumor growth. The carboxylic acid group has been particularly useful for conjugation with targeting ligands or prodrugs, expanding its therapeutic applications.

The chemical synthesis of 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid presents both challenges and opportunities. Advanced synthetic methodologies have been employed to achieve high yields and purity levels. Techniques such as palladium-catalyzed cross-coupling reactions and oxidative cyclizations have been particularly effective in constructing the dioxino[2,3-bpyridine] core. Additionally, green chemistry principles have been integrated into these processes to minimize environmental impact while maintaining efficiency.

The biological evaluation of this compound has revealed intriguing properties that warrant further investigation. In vitro assays have demonstrated that certain derivatives exhibit inhibitory activity against key enzymes implicated in metabolic disorders and neurodegenerative diseases. The chloro substituent appears to play a crucial role in modulating these effects by influencing electronic distribution and steric hindrance around the active site. Furthermore, structural analogs have been synthesized to probe the relationship between molecular structure and biological response.

Recent advances in crystallography have provided valuable insights into the binding modes of 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid derivatives with biological targets. High-resolution structures have elucidated key interactions with protein receptors and enzymes at an atomic level. These findings have guided rational drug design efforts aimed at optimizing potency and selectivity. The integration of computational modeling with experimental data has accelerated the discovery process significantly.

The industrial significance of this compound cannot be overstated. Its synthesis has been scaled up for commercial production under Good Manufacturing Practices (GMP) conditions to support preclinical and clinical development programs. Collaborative efforts between academic institutions and pharmaceutical companies have facilitated rapid translation from bench to market. This underscores the growing recognition of 7-Chloro-2,3-dihydro-1,4-dioxino[2,3-bpyridine]-8-carboxylic acid as a cornerstone molecule in modern drug discovery.

Looking ahead, future research directions for this compound include exploring its potential in combination therapies and personalized medicine approaches. The carboxylic acid functionality offers opportunities for bioconjugation techniques such as click chemistry or proteolysis-targeting chimeras (PROTACs), which could enhance therapeutic efficacy by improving target specificity or delivery mechanisms. Additionally

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)